Hi Mark,
I don't like where the price is as well. I would like to blame management too. However, there are many more issues here. As you have pointed out in the past they have a internal timeline for Indaflex. The problem is they will have to continue to talk to Cypress and see if their timeline is the same. Cypress just bought Proprius and inturn the ownership of certain Research properties. We are in the transitional zone for the purchase so all sides might be silent for a while and the stock could be as well. I hear you I wish you luck with this stock and your other investments. Not to sound like a pumper but, Michael Lee bought quite a bit of stock and they have other product focuses. I still have some patience on that basis.
0 members recommend this.
